ロード中...
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer
The aim of this study was to examine the efficacy and toxicity of the epirubicin, carboplatin and 5-fluorouracil (ECarboF) regime in patients aged 70 or less with metastatic prostate cancer resistant to LHRH analogues. The majority of patients had previously received steroids as part of their system...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2410017/ https://ncbi.nlm.nih.gov/pubmed/15381936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602177 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|